This is a single centre non-inferiority randomized controlled trial in comparison of the bpMRI between the traditional pathway in prostate cancer screening
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Enrollment
500
Men go for the bpMRI for PCa (prostate cancer) screening, those who had a suspicious result will go for the next confirmation test
Men go for the PSA test for PCa screening, those who had a suspicious result will go for the next confirmation test
Shanghai East Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, China
The proportion of men with clinically significant cancer
The presence of a single biopsy core indicating disease of ISUP( international society of urological pathology) 2 or more
Time frame: Within 1 month after the biopsy
The proportion of men with clinically insignificant cancer
The presence of a single biopsy core indicating disease of ISUP( international society of urological pathology) 1
Time frame: Within 1 month after the biopsy
The proportion of men who do not undergo biopsy
The proportion of men who do not need for further biopsy in this trial
Time frame: Within 1 month after the biopsy
The proportion of men with adverse events after the intervention
Any of the adverse events during the trial
Time frame: Within 1 week after the biopsy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.